Genomic and Imaging Study for Patients Undergoing Surgery for Liver Cancer
This clinical trial studies positron emission tomography (PET)/computed tomography (CT) in diagnosing patients with liver cancer undergoing surgical resection. Diagnostic procedures, such as fluorine-18 fluoromethylcholine PET/CT, may help find and diagnose liver cancer.
• Liver tumor diagnosed histologically as HCC or suspected of being HCC in association with serum alpha-fetoprotein level > 200 or tumor mass with characteristics of malignancy on diagnostic imaging
• Under the care of a surgical attending
• Deemed a surgical candidate and has agreed to surgery to remove a portion of the liver containing tumor
• Child-Pugh A/B